logo-loader
RNS
viewSummit Therapeutics PLC

FTSE Russell - Summit Therapeutics

RNS Number : 2596D
FTSE Russell
17 February 2020
 

 

 


 

 

Summit Therapeutics (UK): Constituent Deletion
Changes in FTSE UK Index Series

17 February 2020

Subject to the expected cancellation of trading on AIM for Summit Therapeutics (UK, constituent), please see details of affected indexes and effective dates below:

 

 

Index

Effective From
Start of Trading

FTSE AIM All-Share Index

24 February 2020

 

 

 

 

 

 

 

For further information please contact FTSE Russell Client Services at [email protected] or call:

Australia

+1800 653 680

Hong Kong

+852 2164 3333

Japan

+81 3 4563 6346

London

+44 (0) 20 7866 1810

New York

+1866 551 0617

                                   

 

Alternatively please visit our website at www.ftserussell.com

Terms of Use | Copyright © 2020 FTSE Russell

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
FTSUBANRRNUUAAR

Quick facts: Summit Therapeutics PLC

Price: -

Market: AIM
Market Cap: -
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Summit Therapeutics pleased with new BARDA partnership investment

Summit Therapeutics PLC (NASDAQ:SMMT) (LON:SUMM) Investor Relations Senior Director Michelle Avery sat down with Proactive's Christine Corrado at BIO CEO in New York. The company recently announced The Biomedical Advanced Research and Development Authority (BARDA) is investing a further $8.8mln...

on 02/10/2020